Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
22.64
-0.15 (-0.66%)
Nov 20, 2024, 4:00 PM EST - Market closed

Nurix Therapeutics Income Statement

Millions USD. Fiscal year is Dec - Nov.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018
Period Ending
Aug '24 Nov '23 Nov '22 Nov '21 Nov '20 Nov '19 2018
Revenue
56.4276.9938.6329.7517.8231.12
Upgrade
Revenue Growth (YoY)
-17.76%99.31%29.84%66.95%-42.73%-16.91%
Upgrade
Cost of Revenue
204.12189.15184.5116.4366.4945.03
Upgrade
Gross Profit
-147.7-112.16-145.87-86.68-48.67-13.91
Upgrade
Selling, General & Admin
46.0142.93831.216.318.33
Upgrade
Operating Expenses
46.0142.93831.216.318.33
Upgrade
Operating Income
-193.7-155.06-183.87-117.89-64.98-22.24
Upgrade
Interest & Investment Income
16.9911.123.510.821.210.78
Upgrade
Pretax Income
-176.71-143.95-180.36-117.06-63.78-21.46
Upgrade
Income Tax Expense
0.26--0.13-20.540.24
Upgrade
Net Income
-176.98-143.95-180.36-117.19-43.24-21.7
Upgrade
Net Income to Common
-176.98-143.95-180.36-117.19-43.24-21.7
Upgrade
Shares Outstanding (Basic)
61544943163
Upgrade
Shares Outstanding (Diluted)
61544943163
Upgrade
Shares Change (YoY)
13.03%11.79%13.32%173.68%376.03%16.87%
Upgrade
EPS (Basic)
-2.89-2.65-3.71-2.73-2.76-6.59
Upgrade
EPS (Diluted)
-2.89-2.65-3.71-2.73-2.76-6.59
Upgrade
Free Cash Flow
-106.9-89.77-172.05-90.03-4.63-1.05
Upgrade
Free Cash Flow Per Share
-1.75-1.65-3.54-2.10-0.30-0.32
Upgrade
Gross Margin
-261.76%-145.69%--291.37%-273.14%-44.71%
Upgrade
Operating Margin
-343.30%-201.41%-476.01%-396.26%-364.66%-71.46%
Upgrade
Profit Margin
-313.65%-186.98%-466.93%-393.93%-242.66%-69.74%
Upgrade
Free Cash Flow Margin
-189.45%-116.60%-445.42%-302.61%-26.00%-3.37%
Upgrade
EBITDA
-186.4-148.93-179.72-115.9-62.8-19.88
Upgrade
EBITDA Margin
--193.45%----63.90%
Upgrade
D&A For EBITDA
7.36.134.151.992.182.35
Upgrade
EBIT
-193.7-155.06-183.87-117.89-64.98-22.24
Upgrade
EBIT Margin
--201.41%----71.46%
Upgrade
Revenue as Reported
56.4276.9938.63---
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.